Eszopiclone, CAS 138729-47-2 Sole GMP Manufacturer
Eszopiclone, CAS 138729-47-2 stable novel crystalline or amorphous form both we have, Eszopiclone, CAS 138729-47-2no any IP problem. Eszopiclone, CAS 138729-47-2 DMF filling, free sample of Eszopiclone, CAS 138729-47-2.
EOS Med Chem have already carried out Eszopiclone, CAS 138729-47-2 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Eszopiclone, CAS 138729-47-2 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Eszopiclone, CAS 138729-47-2 Intermeidates list, most from GMP plant:
| Eszopiclone, CAS 138729-47-2 Intermediate 43200-81-3, stock 3.8kg, assay 98.1%, White powder. |
| Eszopiclone, CAS 138729-47-2 Intermediate 39539-66-7, stock 6.7kg, assay 98.5%, White powder. |
| Eszopiclone, CAS 138729-47-2 Intermediate 5130-24-5, stock 7.8kg, assay 98.2%, White powder. |
| Eszopiclone, CAS 138729-47-2 Intermediate 190369-20-1, stock 4.3kg, assay 98.7%, White powder. |
| Eszopiclone, CAS 138729-47-2 Intermediate 190369-21-2, stock 6.9kg, assay 98.5%, White powder. |
| Eszopiclone, CAS 138729-47-2 Intermediate 1400787-78-1, stock 7.5kg, assay 98.9%, White powder. |
| Eszopiclone, CAS 138729-47-2 Intermediate 55112-42-0, stock 9.3kg, assay 98.5%, White powder. |
Eszopiclone, CAS 138729-47-2 HNMR, MASS, COA, MSDS we have.
Eszopiclone, CAS 138729-47-2, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
